Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01354262 · ClinicalTrials.gov registry record · Phase 2
Effect of Vitamin D Supplementation on Hemoglobin A1c
A Phase 2 study, sponsored by Ascension Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT01354262 is a Phase 2 study that has completed, run by Ascension Health. The registered enrollment target is 150 participants.
The verdict
NCT01354262, a Phase 2 study, has completed, sponsored by Ascension Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
This is a prospective, randomized, non-blinded interventional study that will investigate the effect of a vitamin D supplement on HbA1c in patients with uncontrolled type 2 diabetes mellitus (DM) and vitamin D deficiency. The goal is to investigate whether correcting vitamin D deficiency will alter the HbA1c level in patients with type 2 DM and lower than normal vitamin D level. My hypothesis is that correcting vitamin D deficiency decreases HbA1c levels in patients with type 2 DM and vitamin D deficiency.
Interventions
- DIETARY_SUPPLEMENT Vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01354262
The ClinicalTrials.gov registry entry for NCT01354262 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascension Health, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D is the first listed.
NCT01354262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01354262 about?
NCT01354262 is a clinical study titled "Effect of Vitamin D Supplementation on Hemoglobin A1c". This is a prospective, randomized, non-blinded interventional study that will investigate the effect of a vitamin D supplement on HbA1c in patients with uncontrolled type 2 diabetes mellitus (DM) and vitamin D deficiency. The goal is to investigate whether correcting vitamin D deficiency will alter ...
What is the current status of trial NCT01354262?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2011-03. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01354262?
The interventions under investigation include: Vitamin D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01354262?
This trial is sponsored by Ascension Health, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.